Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
12.45
-2.05 (-14.14%)
At close: Nov 20, 2024, 4:00 PM
13.07
+0.62 (4.98%)
After-hours: Nov 20, 2024, 4:08 PM EST
Zenas BioPharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | - | 50 | - |
| Cost of Revenue | 111.44 | 60.03 | 61.69 |
| Gross Profit | -111.44 | -10.03 | -61.69 |
| Selling, General & Admin | 22.64 | 17.11 | 13.51 |
| Operating Expenses | 21.6 | 17.11 | 13.51 |
| Operating Income | -133.04 | -27.15 | -75.2 |
| Interest & Investment Income | 0.7 | 0.7 | - |
| Other Non Operating Income (Expenses) | 3.67 | -0.38 | -43.08 |
| EBT Excluding Unusual Items | -128.67 | -26.82 | -118.28 |
| Pretax Income | -128.67 | -36.82 | -119.28 |
| Income Tax Expense | 0.3 | 0.3 | - |
| Net Income | -128.97 | -37.12 | -119.28 |
| Net Income to Common | -128.97 | -37.12 | -119.28 |
| Shares Outstanding (Basic) | 3 | 2 | 1 |
| Shares Outstanding (Diluted) | 3 | 2 | 1 |
| Shares Change (YoY) | 103.13% | 2.62% | - |
| EPS (Basic) | -41.74 | -24.25 | -79.94 |
| EPS (Diluted) | -41.75 | -24.25 | -79.94 |
| Free Cash Flow | - | -30.55 | -65.85 |
| Free Cash Flow Per Share | - | -19.95 | -44.13 |
| Gross Margin | - | -20.07% | - |
| Operating Margin | - | -54.29% | - |
| Profit Margin | - | -74.25% | - |
| Free Cash Flow Margin | - | -61.09% | - |
| EBITDA | -132.91 | -27.03 | -75.12 |
| EBITDA Margin | - | -54.07% | - |
| D&A For EBITDA | 0.14 | 0.11 | 0.08 |
| EBIT | -133.04 | -27.15 | -75.2 |
| EBIT Margin | - | -54.29% | - |
| Revenue as Reported | - | 50 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.